强脉冲光疗法治疗眼表疾病机制的研究进展  

Advances in related mechanisms of intense pulsed light therapy in ocular surface diseases

作　　者：董文荟 晏晓明[1] Dong Wenhui;Yan Xiaoming(Department of Ophthalmology,Peking University First Hospital,Beijing 100034,China)

机构地区：[1]北京大学第一医院眼科,100034

出　　处：《国际眼科纵览》2020年第5期313-317,共5页International Review of Ophthalmology

基　　金：国家自然科学基金(81870629)。

摘　　要：强脉冲光疗法治疗眼表疾病的适应证已扩展至睑板腺功能障碍等六种疾病,作用机制主要基于选择性光热作用及光生物调节两个理论。除了光热解靶基外,作为强脉冲光重要机制之一的光生物调节作用日益占据重要地位。强脉冲光既能短效改善眼表症状,还能促进睑板腺腺体复苏出现累加治疗效果。(国际眼科纵览,2020,44:313-317)The ocular surface indications of intense pulse light therapy have been extended to six diseases such as meibomian gland dysfunction,and the mechanism of intense pulsed light treatment is mainly based on the two major theories of selective photothermatology and photobiomodulation.In addition to photopyrolysis target substrates,photobiomodulation plays an increasingly essential role as one of the important mechanisms of intense pulsed light.Intense pulsed light can not only improve ocular surface symptoms in a short-term,but also has a cumulative treatment efficacy to promote meibomian gland resuscitation.

关 键 词：强脉冲光 眼表疾病 

分 类 号：R77[医药卫生—眼科]